Naturally occurring splice variants dissect the functional domains of BHC80 and emphasize the need for RNA analysis.

ID (intellectual disability) PHF21A (plant homeodomain finger protein 21A) RNA splicing overgrowth transcriptome

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
24 Jan 2024
Historique:
revised: 04 01 2024
received: 23 11 2023
accepted: 12 01 2024
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 24 1 2024
Statut: aheadofprint

Résumé

Pathogenic PHF21A variation causes PHF21A-related neurodevelopmental disorders (NDDs). Although amorphic alleles, including haploinsufficiency, have been established as a disease mechanism, increasing evidence suggests that missense variants as well as frameshift variants extending the BHC80 carboxyl terminus also cause disease. Expanding on these, we report a proposita with intellectual disability and overgrowth and a novel de novo heterozygous PHF21A splice variant (NM_001352027.3:c.[153+1G>C];[=]) causing skipping of exon 6, which encodes an in-frame BHC80 deletion (p.(Asn30_Gln51del)). This deletion disrupts a predicted leucine zipper domain and implicates this domain in BHC80 function and as a target of variation causing PHF21A-related NDDs. This extension of understanding emphasizes the application of RNA analysis in precision genomic medicine practice.

Identifiants

pubmed: 38264805
doi: 10.1002/ajmg.a.63548
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : BC Children's Hospital Foundation

Informations de copyright

© 2024 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Bradley, R. K., Merkin, J., Lambert, N. J., & Burge, C. B. (2012). Alternative splicing of RNA triplets is often regulated and accelerates proteome evolution. PLoS Biology, 10(1), e1001229. https://doi.org/10.1371/journal.pbio.1001229
Butera, A., Nicotera, A. G., Di Rosa, G., Musumeci, S. A., Vitello, G. A., Musumeci, A., Vinci, M., Gloria, A., Federico, C., Saccone, S., & Cali, F. (2022). PHF21A related disorder: Description of a new case. International Journal of Molecular Sciences, 23(24), 16130. https://doi.org/10.3390/ijms232416130
Chen, H., Chen, Y., Wu, H., Qiu, X., Yu, X., Wang, R., Zhong, J., & Peng, J. (2023). De novo variants in PHF21A cause intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures: A case report and literature review. Seizure, 111, 138-146. https://doi.org/10.1016/j.seizure.2023.08.009
Gazzaz, N., Frost, F. G., Alderman, E., Richmond, P. A., Dalmann, J., Lin, S., Salman, A., Del Bel, K. L., Lehman, A., Turvey, S. E., Boerkoel, C. F., & Cherukuri, P. F. (2022). Can tandem alternative splicing and evasion of premature termination codon surveillance contribute to attenuated Peutz-Jeghers syndrome? American Journal of Medical Genetics. Part A, 188(10), 3089-3095. https://doi.org/10.1002/ajmg.a.62942
Hakimi, M. A., Bochar, D. A., Chenoweth, J., Lane, W. S., Mandel, G., & Shiekhattar, R. (2002). A core-BRAF35 complex containing histone deacetylase mediates repression of neuronal-specific genes. Proceedings of the National Academy of Sciences of the United States of America, 99(11), 7420-7425. https://doi.org/10.1073/pnas.112008599
Hamanaka, K., Sugawara, Y., Shimoji, T., Nordtveit, T. I., Kato, M., Nakashima, M., Saitsu, H., Suzuki, T., Yamakawa, K., Aukrust, I., Houge, G., Mitsuhashi, S., Takata, A., Iwama, K., Alkanaq, A., Fujita, A., Imagawa, E., Mizuguchi, T., Miyake, N., … Matsumoto, N. (2019). De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies. European Journal of Human Genetics, 27(3), 378-383. https://doi.org/10.1038/s41431-018-0289-x
Iwase, S., Januma, A., Miyamoto, K., Shono, N., Honda, A., Yanagisawa, J., & Baba, T. (2004). Characterization of BHC80 in BRAF-HDAC complex, involved in neuron-specific gene repression. Biochemical and Biophysical Research Communications, 322(2), 601-608. https://doi.org/10.1016/j.bbrc.2004.07.163
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alfoldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., … MacArthur, D. G. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434-443. https://doi.org/10.1038/s41586-020-2308-7
Kim, H. G., Kim, H. T., Leach, N. T., Lan, F., Ullmann, R., Silahtaroglu, A., Kurth, I., Nowka, A., Seong, I. S., Shen, Y., Talkowski, M. E., Ruderfer, D., Lee, J. H., Glotzbach, C., Ha, K., Kjaergaard, S., Levin, A. V., Romeike, B. F., Kleefstra, T., … Gusella, J. F. (2012). Translocations disrupting PHF21A in the Potocki-Shaffer-syndrome region are associated with intellectual disability and craniofacial anomalies. American Journal of Human Genetics, 91(1), 56-72. https://doi.org/10.1016/j.ajhg.2012.05.005
Kim, H. G., Rosenfeld, J. A., Scott, D. A., Benedicte, G., Labonne, J. D., Brown, J., McGuire, M., Mahida, S., Naidu, S., Gutierrez, J., Lesca, G., des Portes, V., Bruel, A. L., Sorlin, A., Xia, F., Capri, Y., Muller, E., McKnight, D., Torti, E., … Kim, C. H. (2019). Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism. Molecular Autism, 10, 35. https://doi.org/10.1186/s13229-019-0286-0
Labonne, J. D., Vogt, J., Reali, L., Kong, I. K., Layman, L. C., & Kim, H. G. (2015). A microdeletion encompassing PHF21A in an individual with global developmental delay and craniofacial anomalies. American Journal of Medical Genetics. Part A, 167A(12), 3011-3018. https://doi.org/10.1002/ajmg.a.37344
Maduro, V., Pusey, B. N., Cherukuri, P. F., Atkins, P., du Souich, C., Rupps, R., Limbos, M., Adams, D. R., Bhatt, S. S., Eydoux, P., Links, A. E., Lehman, A., Malicdan, M. C., Mason, C. E., Morimoto, M., Mullikin, J. C., Sear, A., Van Karnebeek, C., Stankiewicz, P., … Boerkoel, C. F. (2016). Complex translocation disrupting TCF4 and altering TCF4 isoform expression segregates as mild autosomal dominant intellectual disability. Orphanet Journal of Rare Diseases, 11(1), 62. https://doi.org/10.1186/s13023-016-0439-6
Mossink, B., Negwer, M., Schubert, D., & Nadif Kasri, N. (2021). The emerging role of chromatin remodelers in neurodevelopmental disorders: A developmental perspective. Cellular and Molecular Life Sciences, 78(6), 2517-2563. https://doi.org/10.1007/s00018-020-03714-5
Poole, R. L., Bijlsma, E. K., Houge, G., Jones, G., Mikstiene, V., Preiksaitiene, E., Thompson, L., & Tatton-Brown, K. (2023). The PHF21A neurodevelopmental disorder: An evaluation of clinical data from 13 patients. Clinical Dysmorphology, 32(2), 49-54. https://doi.org/10.1097/MCD.0000000000000455
Robinson, P. N., Ravanmehr, V., Jacobsen, J. O. B., Danis, D., Zhang, X. A., Carmody, L. C., Gargano, M. A., Thaxton, C. L., Core, U. N. C. B., Karlebach, G., Reese, J., Holtgrewe, M., Kohler, S., McMurry, J. A., Haendel, M. A., & Smedley, D. (2020). Interpretable clinical genomics with a likelihood ratio paradigm. American Journal of Human Genetics, 107(3), 403-417. https://doi.org/10.1016/j.ajhg.2020.06.021

Auteurs

Duha Hejla (D)

Department of Pediatrics, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Stephanie Huynh (S)

Provincial Medical Genetics Program, B.C. Women's Hospital, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Simran Samra (S)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.
Experimental Medicine Program, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Phillip A Richmond (PA)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Joshua Dalmann (J)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Kate L Del Bel (KL)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Loryn Byres (L)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Anna Lehman (A)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Stuart E Turvey (SE)

The Rare Disease Discovery Hub, BC Children's Hospital Research Institute, University of British Columbia and Children's Hospital of British Columbia, Vancouver, British Columbia, Canada.

Cornelius F Boerkoel (CF)

Provincial Medical Genetics Program, B.C. Women's Hospital, Vancouver, British Columbia, Canada.
Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada.

Classifications MeSH